Zambia-Emory HIV Research Project Report issue

Foundation Phase 1 Phase 2

Organization Overview

First Clinical Trial
2005
NCT00888446
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Zambia-Emory HIV Research Project (ZEHRP), Lusaka

Active Ingredients

Drugs in Phase 2 Trials (3)

mmr (1 trial)

tdap-ipv vaccine (1 trial)

tgaac09 (1 trial)

Drugs in Phase 1 Trials (2)

ad35-grin (1 trial)

ad35 investigational hiv vaccine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 2)

Communicable Diseases (Phase 2)

HIV Infections (Phase 2)

Infections (Phase 2)

Virus Diseases (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 5